MedStar Health Type 2 Diabetes Pathway to Control

计划入组 419 人 · 首次发布于 2016 年 10 月 5 日

NRF for Improved Re-Entry Outcomes for Offenders With Brain Injury (Brain Injury RE)

计划入组 1,022 人 · 首次发布于 2023 年 2 月 1 日

DIAGALS: Relation Between Tar DNA Binding Protein(TDP)-43 et Nrf-2 in ALS: a Track to Improve Diagnosis and Prognosis of the Disease

计划入组 60 人 · 首次发布于 2024 年 1 月 30 日

NRF-803

CPC-844

KTX-301

Pathway Therapeutics, Inc.

United States

MEREO BIOPHARMA 2 LIMITED

United Kingdom

UpJohn US 2 LLC

United States

Cbio Receives European Clearance for First-in-Human Trial of Novel T-Cell Therapy in Cervical Cancer

Elizabethtown College and Harford Community College Launch 2+2 Biotechnology Transfer Pathway

LadRx Plans NDA Submission for Aldoxorubicin Under 505(b)(2) Pathway